Korthuis PT

Division of General Internal Medicine and Geriatrics, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.

8 papers · ORCID

ArticlePsilocybin

Oregon's state-regulated psilocybin services: Early real-world safety signals.

Luoma JB, Chwyl C, Des Jarlais D +6

Europe PMC2026
ArticleMDMA

Prevalence of Potential Contraindications and Risk Factors Relevant to MDMA-Assisted Therapy Among U.S. Veterans with Posttraumatic Stress Disorder.

Hwang CS, Cameron DC, O'Neill AC +4

Europe PMC2026
ArticlePsilocybin

Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services.

Korthuis PT, Cook RR, Gregoire D +8

Europe PMC2026
ArticlePsilocybin

Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.

Chwyl C, Wilson-Poe AR, Hoffman KA +6

Europe PMC2026
ArticlePsilocybin

Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs.

Luoma JB, Hoffman K, Wilson-Poe AR +12

Europe PMC2026
ArticlePsilocybin

Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.

Korthuis PT, Hoffman K, Wilson-Poe AR +10

Europe PMC2024
ArticlePsilocybin

Commentary on Darke et al.: Expanded psychedelic access requires new safety monitoring systems.

Korthuis PT, Wilson-Poe AR, Black JC +1

Europe PMC2024
ArticlePsilocybin

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.

Brett J, Knock E, Korthuis PT +5

Europe PMC2023